Literature DB >> 6813341

Beta-galactosidase--an indicator of the maturational stage of mouse and human mononuclear phagocytes.

I Bursuker, J M Rhodes, R Goldman.   

Abstract

Resident, elicited, and activated mouse peritoneal macrophages exhibit a differential expression of the activity of the enzyme beta-galactosidase; freshly harvested resident macrophages express a remarkably high activity whereas the latter two populations are almost void of enzymic activity. During in vitro cultivation there is an enhancement in the level of the enzyme in the three populations, and a significant proportion of both thioglycollate-elicited and Corynebacterium parvum-activated macrophages acquire beta-galactosidase activity. Cells within in vitro differentiated bone marrow-derived mononuclear phagocyte colonies are heterogeneous with respect to expression of beta-galactosidase activity. The percentage of cells expressing medium to intense enzymic activity is augmented with time in culture. Essentially the same pattern is observed in colonies differentiated from bone marrows of mice bearing acute or chronic inflammation. Freshly isolated human peripheral blood monocytes are essentially void of detectable beta-galactosidase activity. Eighty to ninety percent of the monocytes acquire medium to intense activity during a 7-day cultivation period. The data support the suggestion that beta-galactosidase expression in mononuclear phagocytes is a correlate of their maturational stage both in vivo and in vitro and does not reflect the state of elicitation or activation of these cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813341     DOI: 10.1002/jcp.1041120312

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  Isolation and transduction of monocytes: promising vehicles for therapeutic arteriogenesis.

Authors:  Joerg Herold; Harald Tillmanns; Zhou Xing; Ruth H Strasser; Ruediger C Braun-Dullaeus
Journal:  Langenbecks Arch Surg       Date:  2006-03-25       Impact factor: 3.445

Review 2.  Forging a signature of in vivo senescence.

Authors:  Norman E Sharpless; Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2015-07       Impact factor: 60.716

3.  Techniques to Induce and Quantify Cellular Senescence.

Authors:  Nicole Noren Hooten; Michele K Evans
Journal:  J Vis Exp       Date:  2017-05-01       Impact factor: 1.355

Review 4.  Cellular senescence in aging and age-related disease: from mechanisms to therapy.

Authors:  Bennett G Childs; Matej Durik; Darren J Baker; Jan M van Deursen
Journal:  Nat Med       Date:  2015-12       Impact factor: 53.440

5.  Dissection of macrophage tumoricidal and protozoacidal activities using T-cell hybridomas and recombinant lymphokines.

Authors:  W S Futch; L B Schook
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

Review 6.  Mechanisms and functions of cellular senescence.

Authors:  Nicolás Herranz; Jesús Gil
Journal:  J Clin Invest       Date:  2018-04-02       Impact factor: 14.808

Review 7.  Untangling senescent and damage-associated microglia in the aging and diseased brain.

Authors:  Pei Y Ng; Taylor L McNeely; Darren J Baker
Journal:  FEBS J       Date:  2021-12-06       Impact factor: 5.622

8.  Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells.

Authors:  Brandon M Hall; Vitaly Balan; Anatoli S Gleiberman; Evguenia Strom; Peter Krasnov; Lauren P Virtuoso; Elena Rydkina; Slavoljub Vujcic; Karina Balan; Ilya Gitlin; Katerina Leonova; Alexander Polinsky; Olga B Chernova; Andrei V Gudkov
Journal:  Aging (Albany NY)       Date:  2016-07       Impact factor: 5.682

9.  The oncogenic fusion protein RUNX1-CBFA2T1 supports proliferation and inhibits senescence in t(8;21)-positive leukaemic cells.

Authors:  Natalia Martinez; Bettina Drescher; Heidemarie Riehle; Claire Cullmann; Hans-Peter Vornlocher; Arnold Ganser; Gerhard Heil; Alfred Nordheim; Jürgen Krauter; Olaf Heidenreich
Journal:  BMC Cancer       Date:  2004-08-06       Impact factor: 4.430

Review 10.  "Inflammaging" as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 Diabetes.

Authors:  Francesco Prattichizzo; Valeria De Nigris; Lucia La Sala; Antonio Domenico Procopio; Fabiola Olivieri; Antonio Ceriello
Journal:  Oxid Med Cell Longev       Date:  2016-06-01       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.